美股市場個股詳情
IONS Ionis Pharmaceuticals
- 39.040
- +0.240+0.62%
收盤價 11/06 16:00 (美東)
- 38.290
- -0.750-1.92%
盤後 17:17 (美東)
61.57億總市值-16000市盈率TTM
39.960最高價37.180最低價172.84萬股成交量39.950今開38.800昨收6657.10萬成交額1.11%換手率虧損市盈率(靜)1.58億總股本54.44552周最高9.30市淨率61.08億流通值35.95052周最低--股息TTM1.56億流通股86.582歷史最高--股息率TTM7.17%振幅2.500歷史最低38.514平均價1股每手
關於Ionis Pharmaceuticals公司
Ionis Pharmaceuticals Inc是研發新型藥物反義技術的領頭研發者。其廣泛的臨牀和臨牀前管線針對多種疾病，重點是心血管、代謝、神經和罕見疾病。2016 年，Ionis與合作伙伴渤健將治療罕見神經肌肉疾病脊髓性肌萎縮症的Spinraza推向市場，2023 年渤健又推出了肌萎縮側索硬化症(ALS)藥物Qalsody。 Ionis隨後通過其專注於心血管的子公司Akcea將另外兩種藥物推向市場，包括轉甲狀腺素蛋白澱粉樣變性(ATTR)澱粉樣病藥物Tegsedi (2018)和心臟病藥物Waylivra(歐洲，2019)。Ionis和阿斯利康將於2024年推出多發性神經病藥物Wainua。
公司介紹
公司代碼IONS
公司名稱Ionis Pharmaceuticals
上市日期1991/04/17
發行價格57.56
成立日期1989
CEODr. Brett P. Monia, PhD
所屬市場納斯達克
員工數量927
年結日12-31
公司地址2855 Gazelle Court
城市Carlsbad
省份加利福尼亞州
國家美國
郵編92010
電話1-760-931-9200
董事高管
-
姓名
- 職務
- 年薪
-
Dr. Brett P. Monia, PhD
- Chief Executive Officer and Director
- 1250.00萬
-
Patrick R. O'Neil, Esq.
- Chief Legal Officer, General Counsel and Corporate Secretary
- --
-
Eugene Schneider
- Executive Vice President and Chief Clinical Development and Operations Officer
- --
-
Dr. C. Frank Bennett,PhD
- Executive Vice President and Chief Scientific Officer
- --
-
Dr. Richard S. Geary,PhD
- Executive Vice President and Chief Development Officer
- 255.93萬
-
Elizabeth L. Hougen
- Executive Vice President, Finance, Principal Accounting Officer and Chief Financial Officer
- 289.15萬
-
Joseph T. Baroldi
- Executive Vice President and Chief Business Officer
- --
-
Kyle Jenne
- Executive Vice President, Commercial
- --
-
Eric E. Swayze, PhD
- Executive Vice President, Research
- 255.81萬
-
Brian Birchler
- Executive Vice President, Corporate and Development Operations
- --
-
Dr. Joseph Loscalzo, M.D.,PhD
- Chairman of the Board
- 56.80萬
-
B. Lynne Parshall, Esq.,J.D.
- Director
- 53.80萬
-
Dr. Spencer R. Berthelsen,M.D.
- Independent Director
- 54.80萬
-
Dr. Michael Hayden
- Independent Director
- 52.80萬
-
Michael J. Yang
- Independent Director
- 36.31萬
-
Joseph Klein, III
- Independent Director
- 54.20萬
-
Joan E. Herman
- Independent Director
- 54.00萬
-
Allene M. Diaz
- Independent Director
- 53.00萬
-
Joseph H. Wender
- Lead Independent Director
- 59.80萬
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
升跌幅
暫無數據